Global Cancer Biologics Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	243 Pages	TechNavio	March, 2025	INF19892410

Best Price Guarantee
Price	from $2,500
Length	243 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19892410

Cancer Biologics Market 2025-2029

The cancer biologics market is forecasted to grow by USD 84.5 billion during 2024-2029, accelerating at a CAGR of 10.7% during the forecast period. The report on the cancer biologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global incidence of cancer, increased demand for cancer biologics due to emphasis on personalized medicines, and significant therapeutic benefits of cancer biologics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cancer biologics market is segmented as below:

By Product

Monoclonal antibodies
Cell and gene therapy
Vaccines
Others

By Route Of Administration

Injectable
Oral

By Type

Breast cancer
Lung cancer
Colorectal cancer
Prostate cancer
Others

By Distribution Channel

Hospitals
Clinics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the untapped potential of cancer biologics in developing countries as one of the prime reasons driving the cancer biologics market growth during the next few years. Also, rise in research and development for development of innovative cancer biologics and increased use of predictive biomarkers will lead to sizable demand in the market.

The report on the cancer biologics market covers the following areas:

Cancer Biologics Market sizing
Cancer Biologics Market forecast
Cancer Biologics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer biologics market vendors that include Amgen Inc., AstraZeneca PLC, Bayer AG, Biocon Ltd., Biogen Inc., Bristol Myers Squibb Co., Celltrion Co. Ltd., Cipla Inc., DR Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Jazz Pharmaceuticals PLC, Johnson and Johnson Services Inc., Lupin Ltd., Merck KGaA, Novartis AG, Ono Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the cancer biologics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Cancer Biologics Market 2019 - 2023; Historic Market Size - Data Table on Global Cancer Biologics Market 2019 - 2023 ($ billion); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ billion); 5.3 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion); 5.4 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ billion); 5.5 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion); 5.6 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.7 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on Global Cancer Biologics Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Monoclonal antibodies - Market size and forecast 2024-2029; Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); 8.4 Cell and gene therapy - Market size and forecast 2024-2029; Chart on Cell and gene therapy - Market size and forecast 2024-2029 ($ billion); Data Table on Cell and gene therapy - Market size and forecast 2024-2029 ($ billion); Chart on Cell and gene therapy - Year-over-year growth 2024-2029 (%); Data Table on Cell and gene therapy - Year-over-year growth 2024-2029 (%); 8.5 Vaccines - Market size and forecast 2024-2029; Chart on Vaccines - Market size and forecast 2024-2029 ($ billion); Data Table on Vaccines - Market size and forecast 2024-2029 ($ billion); Chart on Vaccines - Year-over-year growth 2024-2029 (%); Data Table on Vaccines - Year-over-year growth 2024-2029 (%); 8.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by Route of Administration: 9.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 9.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 9.3 Injectable - Market size and forecast 2024-2029; Chart on Injectable - Market size and forecast 2024-2029 ($ billion); Data Table on Injectable - Market size and forecast 2024-2029 ($ billion); Chart on Injectable - Year-over-year growth 2024-2029 (%); Data Table on Injectable - Year-over-year growth 2024-2029 (%); 9.4 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ billion); Data Table on Oral - Market size and forecast 2024-2029 ($ billion); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ billion); Data Table on Market opportunity by Route of Administration ($ billion)
10 Market Segmentation by Type: 10.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 10.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 10.3 Breast cancer - Market size and forecast 2024-2029; Chart on Breast cancer - Market size and forecast 2024-2029 ($ billion); Data Table on Breast cancer - Market size and forecast 2024-2029 ($ billion); Chart on Breast cancer - Year-over-year growth 2024-2029 (%); Data Table on Breast cancer - Year-over-year growth 2024-2029 (%); 10.4 Lung cancer - Market size and forecast 2024-2029; Chart on Lung cancer - Market size and forecast 2024-2029 ($ billion); Data Table on Lung cancer - Market size and forecast 2024-2029 ($ billion); Chart on Lung cancer - Year-over-year growth 2024-2029 (%); Data Table on Lung cancer - Year-over-year growth 2024-2029 (%); 10.5 Colorectal cancer - Market size and forecast 2024-2029; Chart on Colorectal cancer - Market size and forecast 2024-2029 ($ billion); Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ billion); Chart on Colorectal cancer - Year-over-year growth 2024-2029 (%); Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%); 10.6 Prostate cancer - Market size and forecast 2024-2029; Chart on Prostate cancer - Market size and forecast 2024-2029 ($ billion); Data Table on Prostate cancer - Market size and forecast 2024-2029 ($ billion); Chart on Prostate cancer - Year-over-year growth 2024-2029 (%); Data Table on Prostate cancer - Year-over-year growth 2024-2029 (%); 10.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 10.8 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
11 Market Segmentation by Distribution Channel: 11.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 11.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 11.3 Hospitals - Market size and forecast 2024-2029; Chart on Hospitals - Market size and forecast 2024-2029 ($ billion); Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion); Chart on Hospitals - Year-over-year growth 2024-2029 (%); Data Table on Hospitals - Year-over-year growth 2024-2029 (%); 11.4 Clinics - Market size and forecast 2024-2029; Chart on Clinics - Market size and forecast 2024-2029 ($ billion); Data Table on Clinics - Market size and forecast 2024-2029 ($ billion); Chart on Clinics - Year-over-year growth 2024-2029 (%); Data Table on Clinics - Year-over-year growth 2024-2029 (%); 11.5 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 11.6 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ billion); Data Table on Market opportunity by Distribution Channel ($ billion)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape: 13.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 13.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 13.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 13.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 13.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 13.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 13.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 13.8 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 13.9 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 13.10 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 13.11 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 13.12 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 13.13 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 13.14 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ billion); Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 13.15 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 13.16 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ billion); Data Table on South Korea - Market size and forecast 2024-2029 ($ billion); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 13.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
14 Drivers, Challenges, and Opportunity/Restraints: 14.1 Market drivers; 14.2 Market challenges; 14.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 14.4 Market opportunities/restraints
15 Competitive Landscape: 15.1 Overview; 15.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 15.3 Landscape disruption; Overview on factors of disruption; 15.4 Industry risks; Impact of key risks on business
16 Competitive Analysis: 16.1 Companies profiled; Companies covered; 16.2 Company ranking index; Company ranking index; 16.3 Market positioning of companies; Matrix on companies position and classification; 16.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 16.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 16.6 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; SWOT; 16.7 Biocon Ltd.; Biocon Ltd. - Overview; Biocon Ltd. - Business segments; Biocon Ltd. - Key offerings; Biocon Ltd. - Segment focus; SWOT; 16.8 Biogen Inc.; Biogen Inc. - Overview; Biogen Inc. - Product / Service; Biogen Inc. - Key news; Biogen Inc. - Key offerings; SWOT; 16.9 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 16.10 Celltrion Co. Ltd.; Celltrion Co. Ltd. - Overview; Celltrion Co. Ltd. - Product / Service; Celltrion Co. Ltd. - Key offerings; SWOT; 16.11 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; SWOT; 16.12 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; SWOT; 16.13 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key offerings; SWOT; 16.14 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 16.15 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; SWOT; 16.16 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 16.17 Jazz Pharmaceuticals Plc; Jazz Pharmaceuticals Plc - Overview; Jazz Pharmaceuticals Plc - Product / Service; Jazz Pharmaceuticals Plc - Key news; Jazz Pharmaceuticals Plc - Key offerings; SWOT; 16.18 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; SWOT
17 Appendix: 17.1 Scope of the report; 17.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 17.3 Currency conversion rates for US$; Currency conversion rates for US$; 17.4 Research methodology; Research methodology; 17.5 Data procurement; Information sources; 17.6 Data validation; Data validation; 17.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 17.8 Data synthesis; Data synthesis; 17.9 360 degree market analysis; 360 degree market analysis; 17.10 List of abbreviations; List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Market Segmentation by Type; Exhibits8: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits9: Executive Summary - Chart on Incremental Growth; Exhibits10: Executive Summary - Data Table on Incremental Growth; Exhibits11: Executive Summary - Chart on Company Market Positioning; Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits13: Overview on criticality of inputs and factors of differentiation; Exhibits14: Overview on factors of disruption; Exhibits15: Impact of drivers and challenges in 2024 and 2029; Exhibits16: Parent Market; Exhibits17: Data Table on - Parent Market; Exhibits18: Market characteristics analysis; Exhibits19: Value chain analysis; Exhibits20: Offerings of companies included in the market definition; Exhibits21: Market segments; Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits26: Historic Market Size - Data Table on Global Cancer Biologics Market 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Product Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion); Exhibits29: Historic Market Size - Type Segment 2019 - 2023 ($ billion); Exhibits30: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion); Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits33: Five forces analysis - Comparison between 2024 and 2029; Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits39: Chart on Market condition - Five forces 2024 and 2029; Exhibits40: Chart on Product - Market share 2024-2029 (%); Exhibits41: Data Table on Product - Market share 2024-2029 (%); Exhibits42: Chart on Comparison by Product; Exhibits43: Data Table on Comparison by Product; Exhibits44: Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Exhibits45: Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Exhibits46: Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Cell and gene therapy - Market size and forecast 2024-2029 ($ billion); Exhibits49: Data Table on Cell and gene therapy - Market size and forecast 2024-2029 ($ billion); Exhibits50: Chart on Cell and gene therapy - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Cell and gene therapy - Year-over-year growth 2024-2029 (%); Exhibits52: Chart on Vaccines - Market size and forecast 2024-2029 ($ billion); Exhibits53: Data Table on Vaccines - Market size and forecast 2024-2029 ($ billion); Exhibits54: Chart on Vaccines - Year-over-year growth 2024-2029 (%); Exhibits55: Data Table on Vaccines - Year-over-year growth 2024-2029 (%); Exhibits56: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits57: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits58: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits60: Market opportunity by Product ($ billion); Exhibits61: Data Table on Market opportunity by Product ($ billion); Exhibits62: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits63: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits64: Chart on Comparison by Route of Administration; Exhibits65: Data Table on Comparison by Route of Administration; Exhibits66: Chart on Injectable - Market size and forecast 2024-2029 ($ billion); Exhibits67: Data Table on Injectable - Market size and forecast 2024-2029 ($ billion); Exhibits68: Chart on Injectable - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Injectable - Year-over-year growth 2024-2029 (%); Exhibits70: Chart on Oral - Market size and forecast 2024-2029 ($ billion); Exhibits71: Data Table on Oral - Market size and forecast 2024-2029 ($ billion); Exhibits72: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits73: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits74: Market opportunity by Route of Administration ($ billion); Exhibits75: Data Table on Market opportunity by Route of Administration ($ billion); Exhibits76: Chart on Type - Market share 2024-2029 (%); Exhibits77: Data Table on Type - Market share 2024-2029 (%); Exhibits78: Chart on Comparison by Type; Exhibits79: Data Table on Comparison by Type; Exhibits80: Chart on Breast cancer - Market size and forecast 2024-2029 ($ billion); Exhibits81: Data Table on Breast cancer - Market size and forecast 2024-2029 ($ billion); Exhibits82: Chart on Breast cancer - Year-over-year growth 2024-2029 (%); Exhibits83: Data Table on Breast cancer - Year-over-year growth 2024-2029 (%); Exhibits84: Chart on Lung cancer - Market size and forecast 2024-2029 ($ billion); Exhibits85: Data Table on Lung cancer - Market size and forecast 2024-2029 ($ billion); Exhibits86: Chart on Lung cancer - Year-over-year growth 2024-2029 (%); Exhibits87: Data Table on Lung cancer - Year-over-year growth 2024-2029 (%); Exhibits88: Chart on Colorectal cancer - Market size and forecast 2024-2029 ($ billion); Exhibits89: Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ billion); Exhibits90: Chart on Colorectal cancer - Year-over-year growth 2024-2029 (%); Exhibits91: Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%); Exhibits92: Chart on Prostate cancer - Market size and forecast 2024-2029 ($ billion); Exhibits93: Data Table on Prostate cancer - Market size and forecast 2024-2029 ($ billion); Exhibits94: Chart on Prostate cancer - Year-over-year growth 2024-2029 (%); Exhibits95: Data Table on Prostate cancer - Year-over-year growth 2024-2029 (%); Exhibits96: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits97: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits98: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits99: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits100: Market opportunity by Type ($ billion); Exhibits101: Data Table on Market opportunity by Type ($ billion); Exhibits102: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits103: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits104: Chart on Comparison by Distribution Channel; Exhibits105: Data Table on Comparison by Distribution Channel; Exhibits106: Chart on Hospitals - Market size and forecast 2024-2029 ($ billion); Exhibits107: Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion); Exhibits108: Chart on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits109: Data Table on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits110: Chart on Clinics - Market size and forecast 2024-2029 ($ billion); Exhibits111: Data Table on Clinics - Market size and forecast 2024-2029 ($ billion); Exhibits112: Chart on Clinics - Year-over-year growth 2024-2029 (%); Exhibits113: Data Table on Clinics - Year-over-year growth 2024-2029 (%); Exhibits114: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits115: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits116: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits117: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits118: Market opportunity by Distribution Channel ($ billion); Exhibits119: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits120: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits121: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits122: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits123: Chart on Geographic comparison; Exhibits124: Data Table on Geographic comparison; Exhibits125: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits126: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits127: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits130: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits131: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits134: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits135: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Asia - Year-over-year growth 2024-2029 (%)